#Cardiovascular | #Inflammatory | #Regenerative

TB-500 (Thymosin Beta-4)

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide that plays a fundamental role in cytoskeletal organization. Its primary biochemical function is the sequestration of G-actin monomers, a process critical for regulating the balance between actin polymerization and depolymerization in cellular motility models.

Peptide Name:

Peptide Class:

Actin-Sequestering Peptide

Sequence Length:

43 Amino Acids

Primary Research Focus:

Actin Dynamics & Cytoskeletal Organization

Form:

Lyophilized Powder

Regulatory Status:

Research Grade Material (RUO)

Chemical Formula:

C₂₁₂H₃₅₀N₅₆O₇₈S

Molecular Weight:

~4,963 g/mol

Structure Note:

TB-500 is a highly conserved, acidic peptide. Its N-terminal sequence is vital for its bioactivity in regulating actin polymerization in eukaryotic cells.

Store lyophilized peptide at −20 °C. Protect from light and moisture.

Reconstitute with sterile or bacteriostatic water. Avoid vigorous agitation to preserve peptide integrity.

Structure Note:

Actin Binding & Cytoskeletal Regulation

The primary mechanism of TB-500 involves its high-affinity binding to G-actin (globular actin). This interaction is fundamental for maintaining the pool of monomeric actin available for polymerization.

Sequestration: By sequestering G-actin, the peptide prevents spontaneous polymerization while maintaining a reservoir of monomers that can be rapidly released when needed for filament growth (F-actin formation).
Cytoskeletal Plasticity: Research investigates how this dynamic equilibrium supports rapid changes in cell shape and mechanical integrity.

Cell Migration & Angiogenesis-Associated Signaling

Cell motility relies heavily on actin polymerization at the leading edge of the cell (lamellipodia). TB-500 is extensively studied in models of endothelial cell migration.

Endothelial Motility: Scratch-assay models measuring endothelial cell migration across monolayer “wounds.”
Tubule Formation: In-vitro studies observing endothelial organization into capillary-like structures on Matrigel matrices.
VEGF Interaction: Research explores the upregulation of vascular endothelial growth factor (VEGF) expression following peptide exposure.

Inflammation-Linked Molecular Pathways

Beyond cytoskeletal effects, TB-500 is investigated for its modulatory role in inflammatory signaling cascades.

NF-κB Pathway: Studies suggest TB-500 may inhibit nuclear translocation of NF-κB, a key transcription factor for pro-inflammatory cytokines.
Cytokine Profiling: Measuring reductions in inflammatory markers such as TNF-α and IL-6 in tissue culture models exposed to inflammatory stimuli.

Cell Survival & Stress-Response Signaling

Experimental evidence indicates cytoprotective effects under cellular stress conditions.

Apoptosis Inhibition: Investigation of anti-apoptotic protein upregulation (e.g., Bcl-2) in cardiomyocytes and neurons exposed to oxidative stress.
H₂O₂ Models: Cell-viability assays using hydrogen-peroxide-induced cytotoxicity models.

Research Limitations

Short Half-Life: Native peptide is rapidly degraded by serum proteases, complicating long-duration in-vivo studies.
Pleiotropic Effects: Because actin is ubiquitous, isolating tissue-specific outcomes can be challenging.
Mechanism Complexity: Downstream signaling linking actin sequestration to transcriptional changes (e.g., VEGF expression) remains incompletely defined.

Scientific References

Huff, T., et al. (2001).
“β-Thymosins, small acidic peptides with multiple functions.”
The International Journal of Biochemistry & Cell Biology, 33(3), 205-220.

Philp, D., et al. (2004).
“Thymosin beta-4 promotes angiogenesis, wound healing, and hair follicle development.”
Mechanisms of Ageing and Development, 125(2), 113-115.

Goldstein, A. L., et al. (2005).
“Thymosin beta-4: actin-sequestering protein moonlights to repair injured tissues.”
Trends in Molecular Medicine, 11(9), 421-429.

Bock-Marquette, I., et al. (2004).
“Thymosin beta-4 activates integrin-linked kinase and promotes cardiac cell migration, survival, and cardiac repair.”
Nature, 432(7016), 466-472.

Dubé, J., & Smart, N. (2018).
“Thymosin beta-4 and the heart: current status and future directions.”
Current Opinion in Pharmacology, 41, 6-11.

The compound listed below is referenced in research contexts related to the mechanisms discussed in this article.

TB-500 (Thymosin Beta-4) is a chemical reference standard intended strictly for in-vitro and laboratory research applications (e.g., actin binding assays, cell migration studies). It is not a drug, dietary supplement, or vaccine adjuvant. It is not intended for human consumption, injection, or therapeutic use. All handling must be performed by qualified professionals in a laboratory setting.

TB-500 (Thymosin Beta-4)

Peptide Name:

Peptide Class:

Sequence Length:

Primary Research Focus:

Form:

Regulatory Status:

Chemical Formula:

Molecular Weight:

Structure Note:

Structure Note:

Age Verification Required

Hospira Bac Water – 30ml

Kisspeptin

GLP1-S

5-Amino-1MQ

Immune & Inflammatory Signaling Bundle

GH Axis & Endocrine Signaling Bundle

Neuro-Signaling & Neuropeptide Bundle

Mitochondrial & Cellular Energy Bundle

Structural & Cytoskeletal Research Bundle